Recombinant Adeno-associated Viral Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Protects Nigral Dopamine Neurons after Onset of Progressive Degeneration in a Rat Model of Parkinson's Disease
- 30 November 1999
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 160 (1), 205-214
- https://doi.org/10.1006/exnr.1999.7203
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- A commentary on glial cell line-derived neurotrophic factor (GDNF): From a glial secreted molecule to gene therapyBiochemical Pharmacology, 1999
- Behavioral and Cellular Protection of Rat Dopaminergic Neurons by an Adenoviral Vector Encoding Glial Cell Line-Derived Neurotrophic FactorExperimental Neurology, 1998
- Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in BrainHuman Gene Therapy, 1998
- Gene Therapies for Parkinson’s DiseasePublished by Springer Nature ,1998
- Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson diseaseProceedings of the National Academy of Sciences, 1997
- Dopaminergic Neurons Protected from Degeneration by GDNF Gene TherapyScience, 1997
- Studies on Neuroprotective and Regenerative Effects of GDNF in a Partial Lesion Model of Parkinson's DiseaseNeurobiology of Disease, 1997
- 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the ratExperimental Brain Research, 1996
- Glial cell line-derived neurotrophic factor reverses motor impairment in 16–17 month old ratsNeuroscience Letters, 1996
- Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neuronsJournal of Comparative Neurology, 1995